AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
In Good Company with Nicolai Tangen
Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk
Jul 24, 2024
CEO of Novo Nordisk discusses concerns about medicine access in Europe and the importance of purpose. Topics include obesity, childhood obesity challenges, drug development, corporate cultural differences, and longevity in leadership.
38:48
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Obesity is recognized as a disease influenced by genetics, necessitating effective medications for treatment.
- Global obesity is a universal issue affected by socioeconomic factors, societal structures, and easy access to unhealthy food.
Deep dives
Obesity is a Recognized Disease with Genetic and Lifestyle Factors
Obesity has tripled since 1975, with over 1 billion obese individuals globally. While often attributed to lifestyle choices, it is now recognized as a disease influenced by genetics. Novo Nordisk's research has shown that different people face varied physiological challenges, making traditional weight management difficult, thereby highlighting the necessity for effective medications in combating obesity.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode